Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/05/1998WO1998008865A1 CAP-BINDING DOMAIN OF HUMAN EUKARYOTIC PROTEIN SYNTHESIS INITIATION FACTOR eIF-4E AND THE USE THEREOF
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008862A1 SPECIES SPECIFIC METHOD FOR THE PCR DETECTION OF $i(PHYTHOPHTHORA)
03/05/1998WO1998008861A1 Rp compositions and therapeutic and diagnostic uses therefor
03/05/1998WO1998008860A1 Novel polynucleotide sequences encoding proteins involved in myogenesis
03/05/1998WO1998008607A1 Altering dough viscoelasticity with modified glutenins
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008541A1 Inhibition of primary and/or secondary immune response to repeat adenoviral vector administration using cd40l specific antibodies
03/05/1998WO1998008540A1 Multivalent vaccine for clostridium botulinum neurotoxin
03/05/1998WO1998008536A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
03/05/1998WO1998008535A2 Method of causing selective immunosuppression using hl-60-related lectins
03/05/1998WO1998008534A1 Lymphocyte-derived antimicrobial protein (ldap) and methods of isolating and producing and using the protein
03/05/1998WO1998008530A1 Mhc peptides and methods of use
03/05/1998WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998WO1998008394A1 Method of detecting expression of and isolating the protein encoded by the brca1 gene
03/05/1998WO1998008388A1 Pesticidal agents
03/05/1998WO1998008381A1 Therapeutic and diagnostic applications of perlecan domain i splice variants
03/05/1998WO1998008379A1 Methods for identifying modulators of cellular interactions mediated by osteopontin
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998004586A3 Polynucleotide and its use for modulating a defence response in plants
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001553A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998CA2296765A1 Soluble recombinant botulinum toxin proteins
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264550A1 In vivo protein synthesis method
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264244A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263897A1 Pesticidal agents
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998CA2263824A1 Cd95 regulatory gene sequences and transcription factors
03/05/1998CA2263819A1 Insecticidal protein toxins from photorhabdus
03/05/1998CA2263802A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
03/05/1998CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998CA2262453A1 Modulators of .beta.-amyloid peptide aggregation comprising d-amino acids
03/05/1998CA2235867A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998CA2184780A1 Methods of diagnosing and treating cancer
03/04/1998EP0826965A1 Method for producing a factor V depleted plasma
03/04/1998EP0826775A1 Vector system for conditional gene expression
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826382A2 Biomolecule attachment
03/04/1998EP0826064A1 Low oxygen affinity mutant hemoglobin
03/04/1998EP0826062A1 Hbv vectors and cells for producing the same
03/04/1998EP0826060A2 Embedded expression of heterologous proteins
03/04/1998EP0826058A2 Chimeric mcp and daf proteins with cell surface localizing domain
03/04/1998EP0826055A1 New cathepsin c homolog
03/04/1998EP0826053A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
03/04/1998EP0826052A1 High molecular weight major outer membrane protein of moraxella
03/04/1998EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
03/04/1998EP0826050A1 Modified polypeptides for enhanced immunogenicity
03/04/1998EP0826049A1 Human interferon tau compositions and methods of use
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826047A1 Recombinant baculovirus insecticides
03/04/1998EP0826046A1 Autoantigen which can be used to detect a tendency to thrombosis
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826044A1 Bmp-15 compositions
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826040A1 CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF
03/04/1998EP0826038A2 Soluble, active hepatitis c virus protease
03/04/1998EP0826033A1 Ataxia-telangiectasia gene
03/04/1998EP0826031A1 Ataxia-telangiectasia gene and its genomic organization
03/04/1998EP0826004A1 Storage stable hemoglobin solutions
03/04/1998EP0826003A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/04/1998EP0826002A2 Biologically active peptide fragments of ob protein
03/04/1998EP0826001A1 Acellular pertussis vaccines and methods of preparation thereof
03/04/1998EP0825997A1 Identification of enantiomeric ligands
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825873A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
03/04/1998EP0825872A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
03/04/1998EP0825870A1 Modulation of cytokine patterns of human autoreactive t-cell clones
03/04/1998EP0825811A1 Non-genetically modified mammal as a model for multiple sclerosis
03/04/1998EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/04/1998EP0656121B1 Method for diagnosing and monitoring sepsis
03/04/1998EP0625988A4 Allosteric modulators of the nmda receptor.
03/04/1998EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
03/04/1998EP0565665B1 Preparation of prothrombin time reagents from recombinant human tissue factor and synthetic phospholipids
03/04/1998EP0554389B1 Molecular clones of hiv-1 and uses thereof
03/04/1998EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines
03/04/1998EP0390799B1 Respiratory syncytial virus: vaccines
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175262A Novel receptor
03/04/1998CN1175261A Spray dried erythropoietin
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1174845A Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
03/03/1998US5723765 Control of plant gene expression
03/03/1998US5723763 Plants with modified flowers
03/03/1998US5723760 Genetic engineering
1 ... 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 ... 2916